1. An Overview on Renal and Central Regulation of Blood Pressure by Neuropeptide FF and Its Receptors.
- Author
-
Lee H, Feranil JB, and Jose PA
- Subjects
- Humans, Animals, Oligopeptides metabolism, Central Nervous System metabolism, Central Nervous System physiology, Hypertension metabolism, Hypertension physiopathology, Receptors, Neuropeptide metabolism, Blood Pressure, Kidney metabolism
- Abstract
Neuropeptide FF (NPFF) is an endogenous octapeptide that was originally isolated from the bovine brain. It belongs to the RFamide family of peptides that has a wide range of physiological functions and pathophysiological effects. NPFF and its receptors, NPFFR1 and NPFFR2, abundantly expressed in rodent and human brains, participate in cardiovascular regulation. However, the expressions of NPFF and its receptors are not restricted within the central nervous system but are also found in peripheral organs, including the kidneys. Both NPFFR1 and NPFFR2 mainly couple to Gαi/o, which inhibits cyclic adenosine monophosphate (cAMP) production. NPFF also weakly binds to other RFamide receptors and the Mas receptor. Relevant published articles were searched in PubMed, Google Scholar, Web of Science, and Scopus. Herein, we review evidence for the role of NPFF in the regulation of blood pressure, in the central nervous system, particularly within the hypothalamic paraventricular nucleus and the brainstem, and the kidneys. NPFF is a potential target in the treatment of hypertension.
- Published
- 2024
- Full Text
- View/download PDF